Hansen P B, Friis U G, Uhrenholt T R, Briggs J, Schnermann J
National Institute of Diabetes, and Digestive and Kidney Diseases, NIH, Bethesda, MD, USA.
Acta Physiol (Oxf). 2007 Oct;191(2):89-97. doi: 10.1111/j.1748-1716.2007.01724.x. Epub 2007 Jun 12.
Adenosine causes vasoconstriction of afferent arterioles of the mouse kidney through activation of adenosine A(1) receptors and Gi-mediated stimulation of phospholipase C. In the present study, we further explored the signalling pathways by which adenosine causes arteriolar vasoconstriction.
Adenosine (10(-7) M) significantly increased the intracellular calcium concentration in mouse isolated afferent arterioles measured by fura-2 fluorescence. Pre-treatment with thapsigargin (2 microM) blocked the vasoconstrictor action of adenosine (10(-7) M) indicating that release of calcium from the sarcoplasmic reticulum (SR), stimulated presumably by IP(3), is involved in the adenosine contraction mechanism of the afferent arteriole. In agreement with this notion is the observation that 2 aminoethoxydiphenyl borate (100 microM) blocked the adenosine-induced constriction whereas the protein kinase C inhibitor calphostin C had no effect. The calcium-activated chloride channel inhibitor IAA-94 (30 microM) inhibited the adenosine-mediated constriction. Patch clamp experiments showed that adenosine treatment induced a depolarizing current in preglomerular smooth muscle cells which was abolished by IAA-94. Furthermore, the vasoconstriction caused by adenosine was significantly inhibited by 5 microM nifedipine (control 8.3 +/- 0.2 microM, ado 3.6 +/- 0.6 microM, ado + nifedipine 6.8 +/- 0.2 microM) suggesting involvement of voltage-dependent calcium channels.
We conclude that adenosine mediates vasoconstriction of afferent arterioles through an increase in intracellular calcium concentration resulting from release of calcium from the SR followed by activation of Ca(2+)-activated chloride channels leading to depolarization and influx of calcium through voltage-dependent calcium channels.
腺苷通过激活腺苷A(1)受体和Gi介导的磷脂酶C刺激,引起小鼠肾入球小动脉血管收缩。在本研究中,我们进一步探讨了腺苷引起小动脉血管收缩的信号通路。
用fura-2荧光法测定,腺苷(10^(-7) M)可显著提高小鼠离体入球小动脉细胞内钙浓度。用毒胡萝卜素(2 microM)预处理可阻断腺苷(10^(-7) M)的血管收缩作用,表明肌浆网(SR)中钙的释放(可能由IP(3)刺激)参与了入球小动脉的腺苷收缩机制。与此观点一致的是,观察到2-氨基乙氧基二苯硼酸(100 microM)可阻断腺苷诱导的收缩,而蛋白激酶C抑制剂钙泊司汀C则无作用。钙激活氯通道抑制剂IAA-94(30 microM)可抑制腺苷介导的收缩。膜片钳实验表明,腺苷处理可诱导肾小球前平滑肌细胞产生去极化电流,该电流可被IAA-94消除。此外,5 microM硝苯地平可显著抑制腺苷引起的血管收缩(对照组8.3±0.2 microM,腺苷组3.6±0.6 microM,腺苷+硝苯地平组6.8±0.2 microM),提示电压依赖性钙通道参与其中。
我们得出结论,腺苷通过增加细胞内钙浓度介导入球小动脉血管收缩,细胞内钙浓度的增加是由于SR中钙的释放,随后激活钙激活氯通道,导致去极化,并通过电压依赖性钙通道使钙内流。